Electromed, Inc.
Calidad de datos: 100%
ELMD
NYSE
Manufacturing
Measuring & Analyzing Instruments
$24.12
▼
$0.29
(-1.19%)
Cap. Mercado: 201.92 M
Precio
$24.21
Cap. Mercado
201.92 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Puntos Clave
Revenue grew 15.67% annually over 5 years — strong growth
Earnings grew 46.35% over the past year
ROE of 19.94% — decent returns on equity
Generating 8.25 M in free cash flow
PEG of 0.67 suggests growth is underpriced
Cash machine — converts 91.75% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
15.67%
Above sector avg (1.82%)
Revenue (1Y)16.97%
Earnings (1Y)46.35%
FCF Growth (3Y)N/A
Calidad
Return on Equity
19.94%
Above sector avg (-53.53%)
ROIC19.03%
Net Margin13.06%
Op. Margin16.66%
Seguridad
Debt / Equity
N/A
Current Ratio4.86
Interest CoverageN/A
Valoración
PE (TTM|2027)
22.46 | 18.34
Above sector avg (-1.48)
P/B Ratio4.44
EV/EBITDA16.40
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1366 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1366 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 22.5 | -1.5 |
| P/B | 4.4 | 1.6 |
| ROE % | 19.9 | -53.5 |
| Net Margin % | 13.1 | -41.5 |
| Rev Growth 5Y % | 15.7 | 1.8 |
| D/E | — | 0.3 |
Precio Objetivo de Analistas
4 analistas
Buy
Actual
$24.12
Objetivo
$37.00
$36.00
$37.00
$38.00
Pronóstico
P/E Futuro
18.27
EPS Futuro
$1.32
Crecimiento EPS (est.)
+20.0%
Ingresos Est.
80.86 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$1.32
$1.29 – $1.36
|
80.86 M | 4 |
| FY2026 |
$1.10
$1.09 – $1.11
|
72.53 M | 4 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
$0.30
$0.28 – $0.31
|
19.25 M | 4 |
| 2026 Q1 |
$0.24
$0.22 – $0.26
|
17.53 M | 4 |
Sorpresas de Ganancias
Últimos 6 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | $0.26 | $0.32 | +23.1% |
| Q32025 | $0.21 | $0.25 | +22.0% |
| Q22025 | $0.22 | $0.25 | +16.3% |
| 2026-Q2 | $0.30 | $0.31 | +4.2% |
| 2026-Q1 | $0.24 | $0.25 | +3.1% |
| Q12025 | $0.20 | $0.21 | +5.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.97% | Revenue Growth (3Y) | 15.39% |
| Earnings Growth (1Y) | 46.35% | Earnings Growth (3Y) | 54.29% |
| Revenue Growth (5Y) | 15.67% | Earnings Growth (5Y) | 33.65% |
| Profitability | |||
| Revenue (TTM) | 68.86 M | Net Income (TTM) | 8.99 M |
| ROE | 19.94% | ROA | 16.57% |
| Gross Margin | 78.23% | Operating Margin | 16.66% |
| Net Margin | 13.06% | Free Cash Flow (TTM) | 8.25 M |
| ROIC | 19.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.86 |
| Interest Coverage | N/A | Asset Turnover | 1.27 |
| Working Capital | 36.19 M | Tangible Book Value | 45.05 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 22.46 | Forward P/E | N/A |
| P/B Ratio | 4.44 | P/S Ratio | 2.93 |
| PEG Ratio | 0.67 | Forward PEG | N/A |
| EV/EBITDA | 16.40 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 4.09% | ||
| Market Cap | 201.92 M | Enterprise Value | 188.13 M |
| Per Share | |||
| EPS (Diluted TTM) | 1.03 | Revenue / Share | 8.26 |
| FCF / Share | 0.99 | OCF / Share | 1.09 |
| EPS CAGR (1Y) | 46.55% | EPS CAGR (5Y) | 33.20% |
| EPS CAGR (10Y) | 13.59% | ||
| Efficiency | |||
| CapEx / Revenue | 1.28% | FCF Conversion | 91.75% |
| SBC-Adj. FCF | 5.68 M | Growth Momentum | 1.30 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 64.00 M | 54.72 M | 48.07 M | 41.66 M | 35.76 M |
| Net Income | 7.54 M | 5.15 M | 3.17 M | 2.31 M | 2.36 M |
| EPS (Diluted) | 0.85 | 0.58 | 0.36 | 0.26 | 0.27 |
| Gross Profit | 49.97 M | 41.73 M | 36.52 M | 31.44 M | 27.31 M |
| Operating Income | 9.66 M | 6.58 M | 4.01 M | 2.97 M | 3.14 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 996,000.0 | 656,000.0 | 916,000.0 | 1.36 M | 1.72 M |
| SG&A Expenses | 39.32 M | 34.49 M | 31.60 M | 27.11 M | 22.44 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | 455,000.0 | 78,000.0 | 25,000.0 | 39,000.0 |
| Income Tax | 2.75 M | 1.89 M | 920,000.0 | 692,000.0 | 805,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53.80 M | 52.23 M | 45.81 M | 41.36 M | 37.11 M |
| Total Liabilities | 10.59 M | 7.69 M | 8.14 M | 7.19 M | 4.69 M |
| Shareholders' Equity | 43.21 M | 44.55 M | 37.67 M | 34.17 M | 32.42 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 15.29 M | 16.08 M | 7.37 M | 8.15 M | 11.89 M |
| Current Assets | 45.08 M | 44.17 M | 37.79 M | 34.54 M | 31.70 M |
| Current Liabilities | 10.47 M | 7.68 M | 8.05 M | 7.15 M | 4.64 M |
{"event":"ticker_viewed","properties":{"ticker":"ELMD","listing_kind":"stock","pathname":"/stocks/elmd","exchange":"NYSE","country":"US"}}